$CYTH
Cyclo Therapeutics, Inc.

2022 Q3 Form 10-Q Financial Statement

#000143774922020532 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $452.2K $541.9K $194.9K
YoY Change 11.95% 127.12% -45.58%
Cost Of Revenue $35.21K $77.34K $20.79K
YoY Change 40.28% 143.13% -42.66%
Gross Profit $417.0K $464.6K $174.1K
YoY Change 10.07% 124.66% -45.91%
Gross Profit Margin 92.21% 85.73% 89.33%
Selling, General & Admin $1.804M $2.041M $2.020M
YoY Change -24.7% 76.16% 84.04%
% of Gross Profit 432.7% 439.44% 1160.06%
Research & Development $2.856M $1.874M $1.084M
YoY Change 55.42% -29.1% -66.73%
% of Gross Profit 685.0% 403.48% 622.62%
Depreciation & Amortization $5.130K $4.740K $4.741K
YoY Change 21.85% -2.47% 33.55%
% of Gross Profit 1.23% 1.02% 2.72%
Operating Expenses $2.856M $1.874M $1.084M
YoY Change 55.42% -29.1% -66.73%
Operating Profit -$4.249M -$3.456M -$2.934M
YoY Change 10.09% -4.01% -27.32%
Interest Expense $1.620K $4.030K $4.340K
YoY Change -230.65% 32.13% 557.58%
% of Operating Profit
Other Income/Expense, Net $1.620K $4.034K $162.9K
YoY Change -230.65% 32.09% 24539.33%
Pretax Income -$4.247M -$3.452M -$2.772M
YoY Change 10.02% -4.04% -31.34%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.247M -$3.452M -$2.772M
YoY Change 10.02% -4.04% -31.34%
Net Earnings / Revenue -939.23% -637.03% -1422.03%
Basic Earnings Per Share -$0.50 -$0.41 -$0.33
Diluted Earnings Per Share -$502.7K -$410.1K -$329.5K
COMMON SHARES
Basic Shares Outstanding 8.439M 8.424M 8.412M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.290M $7.453M $11.80M
YoY Change -49.18% -34.98% -23.91%
Cash & Equivalents $4.290M $7.453M $11.80M
Short-Term Investments
Other Short-Term Assets $3.466M $3.624M $3.673M
YoY Change 82.69% 67.48% 80.36%
Inventory $271.1K $260.6K $221.1K
Prepaid Expenses
Receivables $394.6K $409.9K $118.4K
Other Receivables $0.00 $28.76K $39.34K
Total Short-Term Assets $8.422M $11.78M $15.85M
YoY Change -23.38% -16.6% -12.05%
LONG-TERM ASSETS
Property, Plant & Equipment $60.06K $54.70K $59.44K
YoY Change -5.85% -19.55% 18.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $65.73K $64.78K $73.93K
YoY Change -37.02% -47.25% -38.48%
TOTAL ASSETS
Total Short-Term Assets $8.422M $11.78M $15.85M
Total Long-Term Assets $65.73K $64.78K $73.93K
Total Assets $8.488M $11.84M $15.92M
YoY Change -23.51% -16.86% -12.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.870M $2.092M $2.862M
YoY Change -12.87% -28.61% -21.13%
Accrued Expenses $4.980K $9.810K $14.56K
YoY Change -73.62% -45.53% -20.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Total Short-Term Liabilities $2.875M $2.102M $2.876M
YoY Change -15.92% -30.75% -22.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.875M $2.102M $2.876M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.875M $2.102M $2.876M
YoY Change -17.13% -32.58% -24.7%
SHAREHOLDERS EQUITY
Retained Earnings -$58.82M -$54.57M -$51.12M
YoY Change 29.11% 30.88% 34.18%
Common Stock $846.00 $844.00 $842.00
YoY Change 30.96% 31.06% 32.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.612M $9.740M $13.05M
YoY Change
Total Liabilities & Shareholders Equity $8.488M $11.84M $15.92M
YoY Change -23.51% -16.86% -12.22%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$4.247M -$3.452M -$2.772M
YoY Change 10.02% -4.04% -31.34%
Depreciation, Depletion And Amortization $5.130K $4.740K $4.741K
YoY Change 21.85% -2.47% 33.55%
Cash From Operating Activities -$3.181M -$4.356M -$4.830M
YoY Change 5.11% -1.9% -1.96%
INVESTING ACTIVITIES
Capital Expenditures -$10.49K $0.00 $4.600K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $28.77K $10.57K $13.92K
YoY Change 321.85% -37.23% 318.02%
Cash From Investing Activities $18.28K $10.57K $9.316K
YoY Change 168.04% -286.75% 179.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 $6.778K
YoY Change -100.0% -100.0% -99.91%
NET CHANGE
Cash From Operating Activities -3.181M -4.356M -$4.830M
Cash From Investing Activities 18.28K 10.57K $9.316K
Cash From Financing Activities 0.000 0.000 $6.778K
Net Change In Cash -3.163M -4.345M -$4.814M
YoY Change 4.68% 7.46% -280.94%
FREE CASH FLOW
Cash From Operating Activities -$3.181M -$4.356M -$4.830M
Capital Expenditures -$10.49K $0.00 $4.600K
Free Cash Flow -$3.171M -$4.356M -$4.835M
YoY Change 4.76% -1.4% -1.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Local Phone Number
LocalPhoneNumber
418-8060
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8439435
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8439435
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8403869
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8403869
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
21800 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
52900 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3452000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6224000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54572000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9186000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7453000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2021Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6368025
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
8417901
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
5842100
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-25466
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3029743
dei Entity Address Address Line1
EntityAddressAddressLine1
6714 NW 16th Street, Suite B
dei Entity Address City Or Town
EntityAddressCityOrTown
Gainesville
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32653
dei City Area Code
CityAreaCode
386
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8439435
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7453391 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16612711 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
409932 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
493113 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
260613 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
227437 usd
CY2022Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
28762 usd
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
45977 usd
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
186217 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
42246 usd
CY2022Q2 ctdh Prepaid Expenses Current Excluding Prepaid Insurance
PrepaidExpensesCurrentExcludingPrepaidInsurance
3438121 usd
CY2021Q4 ctdh Prepaid Expenses Current Excluding Prepaid Insurance
PrepaidExpensesCurrentExcludingPrepaidInsurance
2014851 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
11777036 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
19436335 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54701 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59583 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10078 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17636 usd
CY2022Q2 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
0 usd
CY2021Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
7279 usd
CY2022Q2 us-gaap Assets
Assets
11841815 usd
CY2021Q4 us-gaap Assets
Assets
19520833 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9805 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19245 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
133712 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2091968 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3677979 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2101773 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3830936 usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
18034 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
844 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
841 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64311270 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64019513 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54572072 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48348491 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
9740042 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15671863 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11841815 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19520833 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
541886 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
238590 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
736790 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
596723 usd
CY2022Q2 us-gaap Salaries And Wages
SalariesAndWages
970759 usd
CY2021Q2 us-gaap Salaries And Wages
SalariesAndWages
542192 usd
us-gaap Salaries And Wages
SalariesAndWages
2187664 usd
us-gaap Salaries And Wages
SalariesAndWages
1101516 usd
CY2022Q2 ctdh Cost Of Goods And Services Sold Excluding Direct And Indirect Overhead And Handling Costs
CostOfGoodsAndServicesSoldExcludingDirectAndIndirectOverheadAndHandlingCosts
73667 usd
CY2021Q2 ctdh Cost Of Goods And Services Sold Excluding Direct And Indirect Overhead And Handling Costs
CostOfGoodsAndServicesSoldExcludingDirectAndIndirectOverheadAndHandlingCosts
30158 usd
ctdh Cost Of Goods And Services Sold Excluding Direct And Indirect Overhead And Handling Costs
CostOfGoodsAndServicesSoldExcludingDirectAndIndirectOverheadAndHandlingCosts
90131 usd
ctdh Cost Of Goods And Services Sold Excluding Direct And Indirect Overhead And Handling Costs
CostOfGoodsAndServicesSoldExcludingDirectAndIndirectOverheadAndHandlingCosts
64754 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1874383 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2643544 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2958435 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5901659 usd
CY2022Q2 ctdh Repairs And Maintenance
RepairsAndMaintenance
3675 usd
CY2021Q2 ctdh Repairs And Maintenance
RepairsAndMaintenance
1647 usd
ctdh Repairs And Maintenance
RepairsAndMaintenance
7998 usd
ctdh Repairs And Maintenance
RepairsAndMaintenance
3313 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
649842 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
373618 usd
us-gaap Professional Fees
ProfessionalFees
1061897 usd
us-gaap Professional Fees
ProfessionalFees
596489 usd
CY2022Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
291611 usd
CY2021Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
241739 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
585787 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
555513 usd
CY2022Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
124131 usd
CY2021Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
0 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
216256 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
0 usd
CY2022Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
4741 usd
CY2021Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
4863 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
9482 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
8413 usd
CY2022Q2 ctdh Freight And Shipping
FreightAndShipping
5101 usd
CY2021Q2 ctdh Freight And Shipping
FreightAndShipping
1281 usd
ctdh Freight And Shipping
FreightAndShipping
9621 usd
ctdh Freight And Shipping
FreightAndShipping
2794 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
3997910 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
3839042 usd
us-gaap Costs And Expenses
CostsAndExpenses
7127271 usd
us-gaap Costs And Expenses
CostsAndExpenses
8234451 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3456024 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3600452 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6390481 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7637728 usd
CY2022Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
4034 usd
CY2021Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3054 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
8376 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3715 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4034 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3054 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
166900 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3715 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3451990 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3597398 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6223581 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7634013 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3451990 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3597398 usd
us-gaap Net Income Loss
NetIncomeLoss
-6223581 usd
us-gaap Net Income Loss
NetIncomeLoss
-7634013 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.31
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8424003
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6368025
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8417901
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5842100
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15671863 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
106738 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2771591 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
13048014 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
15750 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
41256 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
87012 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3451990 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
9740042 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
10452482 usd
CY2021Q1 ctdh Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
7584092 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4036615 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
14321567 usd
CY2021Q2 ctdh Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
402009 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3597398 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
11126178 usd
us-gaap Net Income Loss
NetIncomeLoss
-6223581 usd
us-gaap Net Income Loss
NetIncomeLoss
-7634013 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9482 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8413 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
158524 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
193750 usd
us-gaap Share Based Compensation
ShareBasedCompensation
50300 usd
ctdh Sharebased Compensation Employees
SharebasedCompensationEmployees
15750 usd
ctdh Sharebased Compensation Employees
SharebasedCompensationEmployees
271308 usd
ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
82260 usd
ctdh Sharebased Compensation Nonemployees
SharebasedCompensationNonemployees
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-83181 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
111414 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
33176 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31021 usd
ctdh Increase Decrease Prepaid Clinical Expenses
IncreaseDecreasePrepaidClinicalExpenses
1423270 usd
ctdh Increase Decrease Prepaid Clinical Expenses
IncreaseDecreasePrepaidClinicalExpenses
1263914 usd
us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
143971 usd
us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
45717 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1587893 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-610727 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-2962411 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-1732772 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9185992 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9366785 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4600 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22500 usd
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-24494 usd
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-20169 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19894 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2331 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
7986101 usd
ctdh Proceeds From Issuance Repayments Of Longterm Debt
ProceedsFromIssuanceRepaymentsOfLongtermDebt
-8159 usd
ctdh Proceeds From Issuance Repayments Of Longterm Debt
ProceedsFromIssuanceRepaymentsOfLongtermDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6778 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7986101 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9159320 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1383015 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16612711 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12846113 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7453391 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11463098 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
21800 usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
52900 usd
us-gaap Use Of Estimates
UseOfEstimates
(q) USE OF ESTIMATES––The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions, including regarding contingencies, that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company’s most significant estimates relate to inventory obsolescence, stock-based compensation and warrant liability valuation. Although management bases its estimates on historical experience and assumptions that are believed to be reasonable under the circumstances, actual results could significantly differ from these estimates.
CY2022Q2 ctdh Working Capital Deficit
WorkingCapitalDeficit
9675000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
541886 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
238590 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
736790 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
596723 usd
CY2016Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
10000 usd
CY2016Q1 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
265000 usd
CY2016Q1 ctdh Mortgage Loans On Real Estate Monthly Payment
MortgageLoansOnRealEstateMonthlyPayment
3653 usd
CY2016Q1 srt Mortgage Loans On Real Estate Interest Rate
MortgageLoansOnRealEstateInterestRate
0.0425 pure
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
209892
CY2022Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
3.26
CY2022Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
3.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
16854
CY2022Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
2.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3451990 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3597398 usd
us-gaap Net Income Loss
NetIncomeLoss
-6223581 usd
us-gaap Net Income Loss
NetIncomeLoss
-7634013 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
8424003
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.31

Files In Submission

Name View Source Status
0001437749-22-020532-index-headers.html Edgar Link pending
0001437749-22-020532-index.html Edgar Link pending
0001437749-22-020532.txt Edgar Link pending
0001437749-22-020532-xbrl.zip Edgar Link pending
ctdh-20220630.xsd Edgar Link pending
ctdh20220630_10q.htm Edgar Link pending
ex_407044.htm Edgar Link pending
ex_407045.htm Edgar Link pending
ex_407046.htm Edgar Link pending
ex_407047.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
ctdh-20220630_def.xml Edgar Link unprocessable
ctdh-20220630_lab.xml Edgar Link unprocessable
ctdh-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ctdh20220630_10q_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ctdh-20220630_cal.xml Edgar Link unprocessable